Lurasidone: Difference between revisions
| [checked revision] | [pending revision] |
MDElliottMD (talk | contribs) Added empty fda_max parameter to MedTemplate call |
MDElliottMD (talk | contribs) Category taxonomy (#23): retag to house-compliant neuroleptic categories |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 22: | Line 22: | ||
| dosing = | | dosing = | ||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 32: | Line 31: | ||
}} | }} | ||
[[Category:Second-generation neuroleptics]] | |||
[[Category:Neuroleptics]] | [[Category:Neuroleptics]] | ||
Latest revision as of 14:41, 22 May 2026
Antipsychotic, Neuroleptic
Lurasidone
Latuda
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Antipsychotic, Neuroleptic
Common uses
Pharmacy
Pharmacology
Purported mechanism
D2/5-HT2A antagonist; 5-HT7 antagonist